Catalent, Inc. (CTLT) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
14 SCHOOLHOUSE ROAD SOMERSET, NJ 08873 |
| State of Incorp. | DE |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)Annual | Quarterly
| 9/30/2022 Q1 | 6/30/2022 Q4 | 3/31/2022 Q3 | 12/31/2021 Q2 | 9/30/2021 Q1 | 6/30/2021 Q4 | 3/31/2021 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 281 | 449 | 786 | 849 | 1,969 | 896 | 988 | ||
| Cash and cash equivalents | 281 | 449 | 786 | 849 | 1,969 | 896 | 988 | ||
| Receivables | 989 | 1,051 | 932 | 871 | 831 | 1,012 | 835 | ||
| Inventory, net of allowances, customer advances and progress billings | 732 | 702 | 676 | 688 | 622 | 563 | 528 | ||
| Inventory | 732 | 702 | 676 | 688 | 622 | 563 | 528 | ||
| Prepaid expense | 72 | 61 | 74 | 54 | 64 | 46 | 47 | ||
| Contract with customer, asset | 418 | 327 | 308 | 224 | 177 | ||||
| Disposal group, including discontinued operation | 47 | ||||||||
| Other current assets | 59 | 70 | 56 | 61 | 53 | 47 | 37 | ||
| Other undisclosed current assets | 147 | 583 | 174 | 143 | 168 | 307 | 163 | ||
| Total current assets: | 2,698 | 2,916 | 3,025 | 2,974 | 3,931 | 2,918 | 2,775 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 3,167 | 3,127 | 2,820 | 2,727 | 2,581 | 2,524 | 2,359 | ||
| Intangible assets, net (including goodwill) | 3,946 | 4,066 | 4,109 | 4,158 | 3,324 | 3,336 | 3,350 | ||
| Goodwill | 2,929 | 3,006 | 3,012 | 3,026 | 2,531 | 2,519 | 2,515 | ||
| Intangible assets, net (excluding goodwill) | 1,017 | 1,060 | 1,097 | 1,132 | 793 | 817 | 835 | ||
| Deferred income tax assets | 45 | 68 | 65 | 70 | 44 | ||||
| Other noncurrent assets | 349 | 349 | 300 | 279 | 277 | 268 | 242 | ||
| Other undisclosed noncurrent assets | 49 | 66 | |||||||
| Total noncurrent assets: | 7,507 | 7,591 | 7,297 | 7,229 | 6,252 | 6,194 | 5,995 | ||
| TOTAL ASSETS: | 10,205 | 10,507 | 10,322 | 10,203 | 10,183 | 9,112 | 8,769 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 837 | 1,041 | 1,017 | 1,016 | 1,017 | 1,121 | 1,066 | ||
| Accounts payable | 379 | 421 | 401 | 363 | 363 | 385 | 366 | ||
| Accrued liabilities | 458 | 620 | 616 | 653 | 654 | 736 | 700 | ||
| Debt | 106 | 31 | 29 | 29 | 79 | 75 | 74 | ||
| Total current liabilities: | 943 | 1,072 | 1,046 | 1,045 | 1,096 | 1,196 | 1,139 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 4,098 | 4,171 | 4,157 | 4,191 | 4,225 | 3,166 | 3,150 | ||
| Finance lease, liability | 217 | 178 | |||||||
| Operating lease, liability | 85 | 73 | |||||||
| Other undisclosed long-term debt and lease obligation | 4,098 | 3,869 | 4,157 | 4,191 | 4,225 | 2,915 | 3,150 | ||
| Liabilities, other than long-term debt | 250 | 267 | 276 | 297 | 311 | 312 | 308 | ||
| Liability, pension and other postretirement and postemployment benefits | 98 | 103 | 122 | 127 | 133 | 137 | 140 | ||
| Other liabilities | 152 | 164 | 154 | 170 | 178 | 175 | 168 | ||
| Other undisclosed noncurrent liabilities | 214 | 202 | 211 | 189 | 171 | 164 | 100 | ||
| Total noncurrent liabilities: | 4,562 | 4,640 | 4,644 | 4,677 | 4,707 | 3,642 | 3,558 | ||
| Total liabilities: | 5,505 | 5,712 | 5,690 | 5,722 | 5,803 | 4,838 | 4,697 | ||
| Temporary equity, carrying amount | 359 | 359 | 359 | ||||||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 4,700 | 4,795 | 4,632 | 4,481 | 4,021 | 3,915 | 3,713 | ||
| Additional paid in capital | 4,674 | 4,649 | 4,630 | 4,615 | 4,234 | 4,205 | 4,186 | ||
| Accumulated other comprehensive loss | (514) | (394) | (350) | (345) | (329) | (317) | (324) | ||
| Retained earnings (accumulated deficit) | 538 | 538 | 350 | 209 | 114 | 25 | (150) | ||
| Other undisclosed stockholders' equity attributable to parent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||
| Total stockholders' equity: | 4,700 | 4,795 | 4,632 | 4,481 | 4,021 | 3,915 | 3,713 | ||
| TOTAL LIABILITIES AND EQUITY: | 10,205 | 10,507 | 10,322 | 10,203 | 10,183 | 9,112 | 8,769 | ||
Income Statement (P&L) ($ in millions) Annual | Quarterly
| 9/30/2022 Q1 | 6/30/2022 Q4 | 3/31/2022 Q3 | 12/31/2021 Q2 | 9/30/2021 Q1 | 6/30/2021 Q4 | 3/31/2021 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,022 | 1,313 | 1,273 | 1,217 | 1,025 | 1,188 | 1,053 | |
| Cost of revenue (Cost of Goods and Services Sold) | (764) | (825) | (850) | (812) | (701) | (749) | (688) | |
| Gross profit: | 258 | 488 | 423 | 405 | 324 | 439 | 366 | |
| Operating expenses | (198) | (242) | (212) | (244) | (187) | (194) | (176) | |
| Other undisclosed operating income | 1 | 6 | 179 | |||||
| Operating income: | 60 | 246 | 211 | 161 | 138 | 251 | 369 | |
| Nonoperating income (expense) | (25) | (3) | (2) | (14) | (9) | 2 | (25) | |
| Investment income, nonoperating | (8) | (2) | (2) | 185 | ||||
| Foreign currency transaction loss, before tax | (27) | (5) | (4) | (15) | (9) | (3) | (7) | |
| Other nonoperating income (expense) | (1) | 2 | 2 | 1 | 4 | 2 | (1) | |
| Interest and debt expense | 4 | (1) | 4 | 1 | ||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (33) | (27) | ||||||
| Income from continuing operations before equity method investments, income taxes: | 39 | 242 | 209 | 147 | 133 | 222 | 317 | |
| Other undisclosed loss from continuing operations before income taxes | (36) | (31) | (33) | (32) | (30) | |||
| Income from continuing operations before income taxes: | 3 | 211 | 176 | 115 | 103 | 222 | 317 | |
| Income tax expense | (3) | (23) | (35) | (18) | (10) | (39) | (85) | |
| Net income attributable to parent: | 188 | 141 | 97 | 93 | 182 | 232 | ||
| Other undisclosed net loss available to common stockholders, basic | (1) | (4) | (9) | (14) | (15) | |||
| Net income available to common stockholders, diluted: | 187 | 141 | 93 | 84 | 169 | 217 | ||
Comprehensive Income ($ in millions)Annual | Quarterly
| 9/30/2022 Q1 | 6/30/2022 Q4 | 3/31/2022 Q3 | 12/31/2021 Q2 | 9/30/2021 Q1 | 6/30/2021 Q4 | 3/31/2021 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 188 | 141 | 97 | 93 | 182 | 232 | ||
| Other comprehensive income (loss) | (120) | (44) | (5) | (16) | (12) | 7 | 6 | |
| Comprehensive income (loss), net of tax, attributable to parent: | (120) | 144 | 136 | 81 | 81 | 189 | 238 | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.